Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationlly. Its products include human albumin; intravenous human immunoglobulin; rabies patient immunoglobulin; tetanus human immunoglobulin; hepatitis B human immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Metrics to compare | 600161 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600161PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.9x | 29.9x | −0.7x | |
PEG Ratio | 1.83 | 0.42 | 0.00 | |
Price/Book | 3.3x | 2.2x | 2.6x | |
Price / LTM Sales | 6.0x | 6.8x | 3.4x | |
Upside (Analyst Target) | 31.0% | 17.2% | 37.6% | |
Fair Value Upside | Unlock | 7.3% | 4.6% | Unlock |